Literature DB >> 19878104

The association of ocular blood flow with haemorheological parameters in primary open-angle and exfoliative glaucoma.

Mehmet Ali Sekeroglu1, Murat Irkec, Mehmet Cem Mocan, Esin Ileri, Neslihan Dikmenoglu, Nurten Seringec, Devrim Karaosmanoglu, Mehmet Orhan.   

Abstract

PURPOSE: To evaluate the ocular blood flow velocities and haemorheological parameters in patients with primary open-angle glaucoma (POAG), exfoliative glaucoma (XFG) and exfoliation syndrome (XFS) and to compare their results with those of healthy controls.
METHODS: Twenty-five patients with POAG (group 1), 25 patients with XFG (group 2), 25 patients with XFS (group 3) and 25 healthy controls (group 4) were included in the study. Ocular blood flow velocities of ophthalmic artery (OA), central retinal artery (CRA) and short posterior ciliary arteries (SPCAs) were measured using colour Doppler imaging (CDI). Haemorheological parameters (erythrocyte elongation and aggregation index, aggregation amplitude, aggregation half-life, plasma viscosity, haematocrit) were measured in venous blood samples of all patients.
RESULTS: The peak systolic velocity (PSV) and end-diastolic velocity (EDV) values were lower and resistive indices (RI) were higher for the OA, CRA and SPCA of glaucomatous (groups 1 and 2) patients compared with those of controls (group 4) (PSV: OA, 40.4 ± 11.3 versus 52.6 ± 12.8 cm/second, p < 0.001; CRA, 12.9 ± 2.9 versus 15.3 ± 4.2 cm/second, p = 0.02; SPCA, 21.7 ± 6.6 versus 26.6 ± 8.3 cm/second, p = 0.013) (EDV: OA, 10.3 ± 4.3 versus 14.2 ± 5.1 cm/second, p < 0.001; CRA, 3.7 ± 1.1 versus 4.5 ± 1.3 cm/second, p = 0.025; SPCA, 5.2 ± 1.8 versus 7.7 ± 3.2 cm/second, p = 0.001) (RI: OA, 0.75 ± 0.05 versus 0.66 ± 0.07, p < 0.001; CRA, 0.73 ± 0.08 versus 0.68 ± 0.10, p = 0.223; SPCA, 0.70 ± 0.10 versus 0.63 ± 0.11, p = 0.004). There were no statistically significant differences between the haemorheological parameters of glaucomatous and non-glaucomatous patients. The reduction in ocular blood flow velocities in groups 1, 2 and 3 were not associated with changes in haemorheological parameters.
CONCLUSION: Our results suggest that impairment of the retrobulbar blood flow in POAG and XFG is not associated with alterations in haemorheological parameters.
© 2009 The Authors. Journal compilation © 2009 Acta Ophthalmol.

Entities:  

Mesh:

Year:  2009        PMID: 19878104     DOI: 10.1111/j.1755-3768.2009.01713.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  6 in total

1.  Five-year incidence of primary open-angle glaucoma and rate of progression in health center-based Korean population: the Gangnam Eye Study.

Authors:  Young Kook Kim; Hyuk Jin Choi; Jin Wook Jeoung; Ki Ho Park; Dong Myung Kim
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

Review 2.  Ocular blood flow and cerebrospinal fluid pressure in glaucoma.

Authors:  Véronique Promelle; Joël Daouk; Roger Bouzerar; Benjamin Jany; Solange Milazzo; Olivier Balédent
Journal:  Acta Radiol Open       Date:  2016-02-12

3.  Association between metabolic risk factors and optic disc cupping identified by deep learning method.

Authors:  Jonghoon Shin; Min Seung Kang; Keunheung Park; Jong Soo Lee
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

Review 4.  Changes in peri-ocular anatomy and physiology in pseudoexfoliation syndrome (Review).

Authors:  Efstathios T Detorakis; Georgios Bontzos; Eleni E Drakonaki; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2021-04-19       Impact factor: 2.447

5.  Color Doppler imaging analysis of retrobulbar blood flow velocities in primary open-angle glaucomatous eyes: a meta-analysis.

Authors:  Nana Meng; Ping Zhang; Huadong Huang; Jinlan Ma; Yue Zhang; Hao Li; Yi Qu
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

6.  Role of Oxidative Stress in Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma

Authors:  Yasemin Aydın Yaz; Nilgün Yıldırım; Yetkin Yaz; Neslihan Tekin; Mine İnal; Fezan Mutlu Şahin
Journal:  Turk J Ophthalmol       Date:  2019-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.